Coverage
-
October 01, 2018
An opioid painkiller designed to deter sniffing and injection does not infringe two of Purdue Pharma LP's OxyContin-related patents, a Massachusetts federal judge has ruled in a victory for Collegium Pharmaceutical Inc. and its two-year-old Xtampza XR.
3 other articles on this case.
View all »